Megan Cracchiolo
PhD Student
Pronouns:
she, her, hers
Research Advisor:
Research Topic:
Cancer immunotherapy; hematopoietic stem cell transplantation; pediatric oncology
Selected Publications:
| Baker FL, Stokes J, Cracchiolo MJ, Davini D, Simpson RJ, Katsanis E. Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial. Front Immunol. 2025 Apr 9;16:1568862. doi: 10.3389/fimmu.2025.1568862. PMID: 40270968; PMCID: PMC12014643. Cracchiolo MJ, Davis L, Matiatos AP, Davini DW, Husnain M, Simpson RJ, Voudouris V, Katsanis E. Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies. Cancer Chemother Pharmacol. 2024 Sep;94(3):361-372. doi: 10.1007/s00280-024-04688-y. Epub 2024 Jun 15. PMID: 38878208. Gilman KE, Cracchiolo MJ, Matiatos AP, Davini DW, Simpson RJ, Katsanis E.Partially replacing cyclophosphamide with bendamustine in combination with cyclosporine A improves survival and reduces xenogeneic graft-versus-host-disease. Front Immunol 2023 Jan 9;13:1045710. PMID: 36700195; PMCID: PMC9868157 Gilman KE, Matiatos AP, Cracchiolo MJ, Moon AG, Davini DW, Simpson RJ, Katsanis E. Multiagent intratumoral immunotherapy can be effective in A20 lymphoma clearance and generation of systemic T cell immunity. Cancers. 2023 Mar 24;15(7):1951. PMID: 37046612; PMCID: PMC10093573 |
Degrees
- University of California Los Angeles, BS, Neuroscience, 2021